Tacrolimus
Product Description
Ceres F&D Inc.
-
KR
-
2021On CPHI since
Company types
Categories
Ceres F&D Inc.
-
KR
-
2021On CPHI since
Company types
More Products from Ceres F&D Inc. (1)
-
Product Tergase®
1. Component: - Recombinant human hyaluronidase
2. Indication: - Tergase® is a stand-alone pharmaceutical version of Recombinant human hyaluronidase which is currently under clinical trial aiming marketing approval in the 3Q of 2022 from MFDS, South Korea. Through the inh...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance